Genomic Vision
Genomic vision develops novel diagnostic and drug discovery solutions based on nanotechnology for DNA analysis for cancer and acute diseases.
Business Model:
Revenue: $2.7M
Employees: 11-50
Rankings
Industries / Tags:
Detailed Genomic Vision Information
Geographic Data
Address: 80-84 rue des Meuniers
City: Bagneux
State: île-de-france
Zip: 92220
Country: FR
Financial Info
Stage:
series b
Raised Last:
$6M
Raised Total:$9M
Social
Metrics
3,964,644Website Global Rank
2,720Website Monthly Traffic
Twitter Followers
Description
Genomic vision develops novel diagnostic and drug discovery solutions based on nanotechnology for DNA analysis for cancer and acute diseases.
Contact Phone:
Contact Email:
Genomic Vision went public on 4/11/2014 on the NYSE Euronext
Listed Exchange:
NYSE Euronext
IPO Date:
4/11/2014
Ticker Symbol:
GV
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 3/2014 | IPO | $23M | 7/2008 | Series B | 2 | $6.3M |
Societe Generale Asset Management Vesalius Biocapital Partners Vesalius Biocapital Partners Societe Generale Asset Management Vesalius Biocapital Partners Vesalius Biocapital Partners |
12/2005 | Series A | 1 | $2.4M |
Societe Generale Asset Management Societe Generale Asset Management |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
